Study S002348

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Informed Consent Form (PDF)

Registration

Registration: NCT06162715
Acronym: GRABS-0
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: NONE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 30
Start: 2024-10-30
Primary completion: 2027-01-01
Lead sponsor: Vanderbilt University Medical Center
Conditions: Severe Obesity; Obesity; BMI Greater Than 30
Interventions: DRUG:Tirzepatide; OTHER:Standard of Care post-gastric bypass
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Weight loss [baseline to 24 weeks]
Gastrointestinal symptoms [baseline to 24 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0000681	GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics. Samuels JM, Diabetes, obesity & metabolism	2026	Protocol	PMID 42712125 DOI	cites ClinicalTrials.gov:NCT06162715; registry reference DERIVED:42712125